Postmortem Forensic Toxicology of Trazodone
Authors:
- 1 July 2000
- journal article
- case report
- Published by ASTM International in Journal of Forensic Sciences
- Vol. 45 (4) , 850-856
Abstract
Trazodone is a popular antidepressant medication that has been available for approximately 30 years. It has a reputation as a safe drug with relatively few reported fatalities attributed solely to it. We review the pharmacology and forensic toxicology of trazodone and report toxicology and cause and manner of death in a series of 37 deaths in which trazodone was detected. Although the normal upper therapeutic blood concentration for trazodone is about 2 mg/L, fatalities are rarely attributed solely to it at blood concentrations below 9 mg/L. Considering the pharmacology of the drug, potential interactions between other drugs with serotonin reuptake properties need to be considered, as does the increased susceptibility to the toxic effects in patients with pre-existing heart disease. In the cases reviewed, none were attributed solely to trazodone, although trazodone was frequently present together with other serotonergic drugs, such as the selective serotonin reuptake inhibitors like fluoxetine and sertraline. Ten cases had blood trazodone concentrations above 2 mg/L. Of these cases, trazodone played a primary role in the death of three subjects, with blood concentrations all greater than 9 mg/L. We confirm the conclusions of others that trazodone is a relatively safe drug except in massive overdose, although its toxicity may be influenced by the presence of other drugs and underlying pathophysiology.Keywords
This publication has 26 references indexed in Scilit:
- Pharmacokinetic Drug Interactions of New Antidepressants: A Review of the Effects on the Metabolism of Other DrugsMayo Clinic Proceedings, 1997
- Trazodone and triazolam: acute subject-rated and performance-impairing effects in healthy volunteersPsychopharmacology, 1997
- Effects of Carbamazepine Coadministration on Plasma Concentrations of Trazodone and Its Active Metabolite, m-ChlorophenylpiperazineTherapeutic Drug Monitoring, 1996
- Primary and secondary oxidative metabolism of dextromethorphan: In vitro studies with female sprague-dawley and dark agouti rat liver microsomesBiochemical Pharmacology, 1993
- Does tolerance develop to the sedative and amnesic effects of antidepressants?European Journal of Clinical Pharmacology, 1991
- A comparison of the effect of flouxetine and trazodone on the cognitive functioning of depressed outpatientsJournal of Affective Disorders, 1990
- United States Experience and Perspectives with TrazodoneClinical Neuropharmacology, 1989
- Determination of a Trazadone Metabolite, 1-m-Chlorophenyl- Piperazine in Plasma by Liquid ChromatographyJournal of Liquid Chromatography, 1985
- Complete heart block following a single dose of trazodoneAmerican Journal of Psychiatry, 1984
- Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodoneJournal of Pharmacy and Pharmacology, 1982